Gentamicin/OVA is a conjugated antigen-adjuvant compound consisting of Gentamicin and ovalbumin (OVA). Conjugating the antigen with a protein adjuvant enhances the production of antigen-specific antibodies in vaccine models. The conjugate does not affect protein folding or disrupt major epitopes, and it improves cross-presentation and the generation of antigen-specific T cells.